Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Daiichi Sankyo
Harvard Business School
Johnson and Johnson
Dow
Farmers Insurance
AstraZeneca
UBS
Express Scripts

Generated: April 24, 2018

DrugPatentWatch Database Preview

OTOBIOTIC Drug Profile

« Back to Dashboard

When do Otobiotic patents expire, and when can generic versions of Otobiotic launch?

Otobiotic is a drug marketed by Schering and is included in one NDA.

The generic ingredient in OTOBIOTIC is hydrocortisone; polymyxin b sulfate. There are sixty-four drug master file entries for this compound. Additional details are available on the hydrocortisone; polymyxin b sulfate profile page.
Summary for OTOBIOTIC
Drug patent expirations by year for OTOBIOTIC
Synonyms for OTOBIOTIC
(8S,9S,10R,11S,13S,14S,17S)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
11-Hydrocortisone
11a-Hydroxycorticosterone
11alpha-Hydroxycorticosterone
11b-Hydrocortisone
11b-Hydroxycortisone
11b,17,21-Trihydroxyprogesterone
17a-Hydroxycorticosterone
4-Pregnene-11alpha,21-triol 3,20-dione
4-Pregnene-11b,17a,21-triol-3,20-dione
AC1LCWC7
BIDD:PXR0064
Cortizol
Hydrocort
Hysone
Neo-Cort-Dome
Otalgine
Otic-Neo-Cort-Dome
Prestwick_265
Proctofoam
Racet
SCHEMBL11648926
ZINC4340309

US Patents and Regulatory Information for OTOBIOTIC

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Schering OTOBIOTIC hydrocortisone; polymyxin b sulfate SOLUTION/DROPS;OTIC 062302-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Deloitte
Covington
Express Scripts
US Department of Justice
Daiichi Sankyo
Chinese Patent Office
Accenture
McKinsey
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.